IDEXX Laboratories Inc.

306.72+0.5900+0.19%Vol 40.15K1Y Perf 24.64%
May 29th, 2020 09:53 DELAYED
BID306.00 ASK307.43
Open307.76 Previous Close306.13
Pre-Market- After-Market306.13
 - -%  - -%
Target Price
290.00 
Analyst Rating
Strong Buy 1.40
Potential %
-6.42 
Finscreener Ranking
     40.59
Insiders Trans % 3/6/12 mo.
-100/-100/-99 
Value Ranking
+     38.03
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     55.51
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap26.05B 
Earnings Rating
Neutral
Price Range Ratio 52W %
96.34 
Earnings Date
30th Apr 2020

Today's Price Range

306.12310.55

52W Range

168.65311.97

5 Year PE Ratio Range

31.0087.10

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
3.87%
1 Month
12.24%
3 Months
20.28%
6 Months
21.68%
1 Year
24.64%
3 Years
82.70%
5 Years
351.52%
10 Years
868.15%

TickerPriceChg.Chg.%
IDXX306.720.59000.19
AAPL319.010.76000.24
GOOG1 427.3210.59000.75
MSFT183.432.03001.12
XOM44.71-0.3300-0.73
WFC26.46-0.7600-2.79
JNJ147.670.70000.48
FB226.831.37000.61
GE6.65-0.1300-1.92
JPM98.59-1.2700-1.27
Financial StrengthValueIndustryS&P 500US Markets
0.50
0.90
0.88
11.75
18.60
Leverage Ratio 10.90
ProfitabilityValueIndustryS&P 500US Markets
56.70
23.00
26.60
18.60
17.78
RevenueValueIndustryS&P 500US Markets
2.46B
28.93
9.24
9.95
Earnings HistoryEstimateReportedSurprise %
Q01 20201.231.294.88
Q04 20190.911.0414.29
Q03 20191.131.249.73
Q02 20191.371.434.38
Q01 20191.041.1712.50
Q04 20180.900.988.89
Q03 20180.981.057.14
Q02 20181.181.234.24
Earnings Per EndEstimateRevision %Trend
6/2020 QR1.14-26.45Negative
9/2020 QR1.27-8.63Negative
12/2020 FY4.91-10.56Negative
12/2021 FY6.04-5.92Negative
Next Report Date-
Estimated EPS Next Report1.23
Estimates Count4
EPS Growth Next 5 Years %10.30
Volume Overview
Volume40.15K
Shares Outstanding84.93M
Trades Count1.11K
Dollar Volume17.39M
Avg. Volume643.27K
Avg. Weekly Volume432.66K
Avg. Monthly Volume508.89K
Avg. Quarterly Volume719.38K

IDEXX Laboratories Inc. (NASDAQ: IDXX) stock closed at 306.13 per share at the end of the most recent trading day (a 1.73% change compared to the prior day closing price) with a volume of 647.59K shares and market capitalization of 26.05B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 8377 people. IDEXX Laboratories Inc. CEO is Jay Mazelsky.

The one-year performance of IDEXX Laboratories Inc. stock is 24.64%, while year-to-date (YTD) performance is 17.23%. IDXX stock has a five-year performance of 351.52%. Its 52-week range is between 168.65 and 311.97, which gives IDXX stock a 52-week price range ratio of 96.34%

IDEXX Laboratories Inc. currently has a PE ratio of 58.90, a price-to-book (PB) ratio of 232.47, a price-to-sale (PS) ratio of 10.19, a price to cashflow ratio of 56.90, a PEG ratio of 2.32, a ROA of 24.49%, a ROC of 36.13% and a ROE of 548.70%. The company’s profit margin is 17.78%, its EBITDA margin is 26.60%, and its revenue ttm is $2.46 Billion , which makes it $28.93 revenue per share.

Of the last four earnings reports from IDEXX Laboratories Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.23 for the next earnings report. IDEXX Laboratories Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for IDEXX Laboratories Inc. is Strong Buy (1.4), with a target price of $290, which is -6.42% compared to the current price. The earnings rating for IDEXX Laboratories Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

IDEXX Laboratories Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

IDEXX Laboratories Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 33.61, ATR14 : 10.08, CCI20 : 166.22, Chaikin Money Flow : 0.03, MACD : 9.17, Money Flow Index : 68.12, ROC : 5.87, RSI : 65.42, STOCH (14,3) : 81.42, STOCH RSI : 1.00, UO : 54.24, Williams %R : -18.58), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of IDEXX Laboratories Inc. in the last 12-months were: Brian P. Mckeon (Option Excercise at a value of $0), Daniel M. Junius (Option Excercise at a value of $255 800), Daniel M. Junius (Sell at a value of $1 182 432), Giovani Twigge (Option Excercise at a value of $776 084), Giovani Twigge (Sold 19 650 shares of value $4 976 582 ), James F. Polewaczyk (Option Excercise at a value of $1 312 162), James F. Polewaczyk (Sold 16 264 shares of value $4 860 515 ), Jay Mazelsky (Option Excercise at a value of $2 723 032), Jay Mazelsky (Sold 28 000 shares of value $7 390 778 ), Jonathan J. Mazelsky (Option Excercise at a value of $3 457 022), Jonathan J. Mazelsky (Sold 36 000 shares of value $9 613 470 ), Jonathan W. Ayers (Option Excercise at a value of $16 805 588), Jonathan W. Ayers (Sold 891 876 shares of value $246 504 882 ), Kathy V. Turner (Option Excercise at a value of $499 787), Kathy V. Turner (Sold 2 690 shares of value $809 690 ), Lawrence D. Kingsley (Buy at a value of $99 904), M. Anne Szostak (Option Excercise at a value of $383 947), M. Anne Szostak (Sold 12 073 shares of value $3 433 632 ), Michael J. Lane (Option Excercise at a value of $3 182 283), Michael J. Lane (Sold 35 922 shares of value $9 486 897 ), Nimrata Hunt (Option Excercise at a value of $0), Rebecca M. Henderson (Option Excercise at a value of $861 095), Rebecca M. Henderson (Sold 17 396 shares of value $4 924 737 ), Sharon E. Underberg (Option Excercise at a value of $0), Sophie V. Vandebroek (Option Excercise at a value of $1 171 080), Sophie V. Vandebroek (Sold 16 612 shares of value $4 557 538 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.40

IDEXX Laboratories Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. Idexx gets about 39% of its revenue from outside the United States.

CEO: Jay Mazelsky

Teplephone: +1 207 556-0300

Address: One IDEXX Drive, Westbrook 04092, ME, USA

Number of employees: 8 377

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

48%52%

Bearish Bullish

51%49%

News

Stocktwits